Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. (2020)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.19.03114
PubMed Identifier: 32552276
Publication URI: http://europepmc.org/abstract/MED/32552276
Type: Journal Article/Review
Volume: 38
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 26
ISSN: 0732-183X